Objective: To analyze the treatment regimen and pharmaceutical care process of severe Mycoplasma pneumoniae pneumonia (SMPP) in children, and provide a reference for drug treatment of SMPP in children. Methods and Results: The child was admitted to the hospital for treatment due to "fever for 7 days and cough for 5 days". In combination with the child's clinical manifestations and examination results, pneumonia was considered; then azithromycin and ceftazidime were administered empirically, supplemented with relieving cough and reducing sputum; but after a full course of azithromycin, the child's symptoms were not alleviated obviously, and the etiological examination reported positive Mycoplasma pneumoniae, which was considered to be resistant to azithromycin; the clinical pharmacist recommended doxycycline after considering the child's age and relevant literature results, and the doctor and family members adopted the recommendation. The child improved and was discharged after 6 days, and the follow-up after 6 weeks showed a good prognosis. Conclusion: Clinical pharmacists participate in the clinical treatment of patients throughout the process and implement pharmaceutical care, which effectively promotes the clinically rational medication and ensures the safety of medication for children.
Key words
severe Mycoplasma pneumoniae pneumonia /
children /
pharmaceutical care /
clinical pharmacist
{{custom_keyword}} /
{{custom_sec.title}}
{{custom_sec.title}}
{{custom_sec.content}}
References
[1] 中华人民共和国国家卫生健康委员会. 儿童肺炎支原体肺炎诊疗指南(2023 年版)[J]. 中国合理用药探索,2023,20(3):16-24.
[2] 中华人民共和国国家卫生健康委员会,国家中医药局. 儿童社区获得性肺炎诊疗规范(2019 年版)[J]. 中华临床感染病杂志,2019,12(1):6-13.
[3] 林巧楠,周鹏翔,翟所迪,等. 注射用阿奇霉素治疗小儿支原体肺炎疗效与安全性的系统评价[J]. 中国药房,2018,29(22):3146-3152.
[4] 周鹏翔,周薇,王晓玲,等. 《儿科阿奇霉素注射使用的快速建议指南》解读[J]. 临床药物治疗杂志,2019,17(7):39-45.
[5] 中国医药教育协会感染疾病专业委员会. 抗菌药物药代动力学/药效学理论临床应用专家共识[J]. 中华结核和呼吸杂志,2018,41(6):409-446.
[6] 临床常用四环素类药物合理应用多学科专家共识编写组.临床常用四环素类药物合理应用多学科专家共识[J]. 中华医学杂志,2023,103(30):2281-2296.
[7] Agwuh KN, MacGowan A. Pharmacokinetics and pharmacodynamics of the tetracyclines including glycylcyclines[J]. J Antimicrob Chemother, 2006, 58(2): 256-265.
[8] Sloan B, Scheinfeld N.The use and safety of doxycycline hyclate and other second-generation tetracyclines[J]. Expert Opin Drug Saf, 2008, 7(5): 571-577.
[9] Stultz JS, Eiland LS.Doxycycline and tooth discoloration in children:changing of recommendations based on evidence of safety[J]. Ann Pharmacother, 2019, 53(11): 1162-1166.
[10] Cross R, Ling C, Day NPJ, et al.Revisiting doxycycline in pregnancy and early childhood: time to rebuild its reputation?[J]. Expert Opin Drug Saf, 2016, 15(3): 367-382.
[11] Pöyhönen H, Nurmi M, Peltola V, et al.Dental staining after doxycycline use in children[J]. J Antimicrob Chemother, 2017, 72(10): 2887-2890.
[12] Todd SR, Dahlgren FS, Traeger MS, et al.No visible dental staining in children treated with doxycycline for suspected Rocky Mountain Spotted Fever[J]. J Pediatr, 2015,166(5):1246-1251.
[13] 齐建光,徐海霞,刘雪芹. 米诺环素治疗儿童肺炎支原体肺炎的研究初探[J]. 中国医刊,2011,46(4):50-52.
[14] 国家药典委员会. 中国药典:临床用药须知[M]. 北京:人民卫生出版社,2005:559.
[15] 《抗菌药物临床应用指导原则》修订工作组. 抗菌药物临床应用指导原则[M]. 北京:人民卫生出版社,2015:57.
[16] 胡亚美,江载芳. 诸福棠实用儿科学[M]. 7 版.北京:人民卫生出版社,2010:874-892.
[17] James EF, Reynolds. Martindale the extra pharmacopoeia:31th[M].London: Royal Pharmaceutical Society, 2000: 129-298.
[18] 刘丽梅,袁拥华,谢梦瑶,等. 左氧氟沙星全身给药儿童骨关节不良事件的系统评价[J]. 中国循证儿科杂志,2015,10(3):193-197.
{{custom_fnGroup.title_en}}
Footnotes
{{custom_fn.content}}
PDF(1565 KB)
